Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenta Okada

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Tobacco Induced Diseases|February 3, 2016
Ankle-brachial index and eicosapentaenoic acid/arachidonic acid ratio in smokers with type 2 diabetes mellitusKenta Okada, Kazuhiko Kotani, Shun Ishibashi
Metabolism: Clinical and Experimental|October 18, 2003
Apolipoprotein CIII deficiency prevents the development of hypertriglyceridemia in streptozotocin-induced diabetic miceToshihiro Takahashi, Tsutomu Hirano, Kenta Okada, et al.
Diabetology & Metabolic Syndrome|August 22, 2014
Eicosapentaenoic acid/arachidonic acid ratio and smoking status in elderly patients with type 2 diabetes mellitusKenta Okada, Kazuhiko Kotani, Hiroaki Yagyu, et al.
Clinical Journal of Gastroenterology|April 26, 2022
Serotonin-positive neuroendocrine neoplasm with pancreatic ductal dilation in which cytological immunostaining contributed to the diagnosisHiroyuki Ariga, Junya Kashimura, Yuichi Horigome, et al.
ACS Omega|April 5, 2021
Crack- and Shrinkage-Free Ethylene-Bridged Polysilsesquioxane Film Prepared by a Hydrosilylation ReactionTakashi Hamada, Yuki Nakanishi, Kenta Okada, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 7, 2004
Olmesartan medoxomil, an angiotensin II receptor blocker ameliorates insulin resistance and decreases triglyceride production in fructose-fed ratsKenta Okada, Tsutomu Hirano, Jianmin Ran, et al.
International Journal of Clinical Pharmacology and Therapeutics|September 13, 2016
Predictors of response to ipragliflozin treatment in patients with type 2 diabetes mellitusKenta Okada, Kazuhiko Kotani, Ken Ebihara, et al.
Journal of Lipid Research|September 3, 2004
Overexpression of apoC-III produces lesser hypertriglyceridemia in apoB-48-only gene-targeted mice than in apoB-100-only miceKarin Conde-Knape, Kenta Okada, Rajasekhar Ramakrishnan, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|December 16, 2020
Safety and efficacy of empagliflozin in elderly Japanese patients with type 2 diabetes mellitus: A post hoc analysis of data from the SACRA studyKenta Okada, Satoshi Hoshide, Mitsutoshi Kato, et al.
Clinical Journal of Gastroenterology|January 5, 2024
Takayasu's arteritis associated with Crohn's disease treated with infliximabHiroyuki Ariga, Yusuke Chino, Takeshi Ojima, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Tobacco Induced Diseases|February 3, 2016
Ankle-brachial index and eicosapentaenoic acid/arachidonic acid ratio in smokers with type 2 diabetes mellitusKenta Okada, Kazuhiko Kotani, Shun Ishibashi
Metabolism: Clinical and Experimental|October 18, 2003
Apolipoprotein CIII deficiency prevents the development of hypertriglyceridemia in streptozotocin-induced diabetic miceToshihiro Takahashi, Tsutomu Hirano, Kenta Okada, et al.
Diabetology & Metabolic Syndrome|August 22, 2014
Eicosapentaenoic acid/arachidonic acid ratio and smoking status in elderly patients with type 2 diabetes mellitusKenta Okada, Kazuhiko Kotani, Hiroaki Yagyu, et al.
Clinical Journal of Gastroenterology|April 26, 2022
Serotonin-positive neuroendocrine neoplasm with pancreatic ductal dilation in which cytological immunostaining contributed to the diagnosisHiroyuki Ariga, Junya Kashimura, Yuichi Horigome, et al.
ACS Omega|April 5, 2021
Crack- and Shrinkage-Free Ethylene-Bridged Polysilsesquioxane Film Prepared by a Hydrosilylation ReactionTakashi Hamada, Yuki Nakanishi, Kenta Okada, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 7, 2004
Olmesartan medoxomil, an angiotensin II receptor blocker ameliorates insulin resistance and decreases triglyceride production in fructose-fed ratsKenta Okada, Tsutomu Hirano, Jianmin Ran, et al.
International Journal of Clinical Pharmacology and Therapeutics|September 13, 2016
Predictors of response to ipragliflozin treatment in patients with type 2 diabetes mellitusKenta Okada, Kazuhiko Kotani, Ken Ebihara, et al.
Journal of Lipid Research|September 3, 2004
Overexpression of apoC-III produces lesser hypertriglyceridemia in apoB-48-only gene-targeted mice than in apoB-100-only miceKarin Conde-Knape, Kenta Okada, Rajasekhar Ramakrishnan, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|December 16, 2020
Safety and efficacy of empagliflozin in elderly Japanese patients with type 2 diabetes mellitus: A post hoc analysis of data from the SACRA studyKenta Okada, Satoshi Hoshide, Mitsutoshi Kato, et al.
Clinical Journal of Gastroenterology|January 5, 2024
Takayasu's arteritis associated with Crohn's disease treated with infliximabHiroyuki Ariga, Yusuke Chino, Takeshi Ojima, et al.
Pageof 5